Keyphrases
Myocarditis
100%
Convalescent Plasma
66%
COVID-19
55%
Sex Differences
47%
Hypermobility
36%
Hypermobile Ehlers-Danlos Syndrome
34%
Heart Failure
26%
Dilated Cardiomyopathy
26%
Comorbidity
24%
Patients with COVID-19
22%
Extracellular Vesicles
21%
COVID-19 Convalescent Plasma
21%
Hospitalized Patients
21%
Convalescent Plasma Therapy
21%
Transfusion
20%
Acute Myocarditis
19%
Coxsackievirus B3 (CVB3)
18%
TRPC6
15%
Viral Myocarditis
15%
Pericarditis
15%
Soluble Suppression of Tumorigenicity 2 (sST2)
15%
Expanded Access
15%
Hypermobile
14%
Meta-analysis
14%
Systematic Meta-analysis
14%
Self-reported Symptoms
14%
Venous Congestion
14%
Hypermobile Spectrum Disorder
14%
Autoimmune
13%
Fibromyalgia
12%
Left Ventricular Ejection Fraction
12%
Cardiovascular Disease
12%
Viral Infection
11%
Trastuzumab
11%
Fibrosis
11%
Autoimmune Disease
11%
Bisphenol A
10%
Antibody Level
10%
Cardiac Function
10%
COVID-19 Patients
10%
Genetic Variants
10%
Male Mice
10%
Ehlers-Danlos Syndrome
9%
Doxorubicin
9%
Inflammation
9%
Disease Pathogenesis
9%
Chemotherapy
9%
Course of COVID-19
9%
Disease Severity
9%
Clinical Course
9%
Medicine and Dentistry
COVID-19
50%
Ehlers Danlos Syndrome
45%
Diseases
40%
Spectrum Disorder
36%
Myocarditis
32%
Sex Difference
29%
Comorbidity
24%
Headache
14%
Dilated Cardiomyopathy
14%
Pericarditis
14%
Venous Congestion
14%
Autoimmunity
13%
Biological Marker
12%
Convalescence
11%
Fibromyalgia
10%
Cardiac Dysrhythmia
10%
Plasma Transfusion
10%
Congestive Heart Failure
10%
Compassionate Use
9%
Prevalence
9%
Infection
9%
Energy-Dispersive X-Ray Spectroscopy
9%
Artificial Respiration
9%
Myocardial Disease
8%
Cardiotoxicity
8%
Cardiovascular System
8%
Disease Course
7%
Cardiovascular Disease
7%
Genetic Variability
7%
Endothelin 1
7%
Coronavirinae
7%
Breast Cancer
7%
Telemedicine
7%
Exon
7%
Pathogenicity
7%
Cell Culture
7%
Upregulation
7%
Pulmonary Hypertension
7%
Immunosuppressive Treatment
7%
Phosphotransferase
7%
Chronic Disease
7%
Molecular Model
7%
Disease Severity
7%
Environmental Influence
7%
Glioblastoma
7%
Doxorubicin
7%
Genetic Code
7%
Retrospective Cohort Study
7%
Meta-Analysis
7%
Protein Function
7%
Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
72%
Diseases
51%
Coronavirinae
25%
Ehlers Danlos Syndrome
23%
Congestive Cardiomyopathy
21%
Cardiovascular Disease
18%
Congestive Heart Failure
17%
Convalescence
16%
Virus Myocarditis
15%
Cardiotoxicity
14%
Comorbidity
14%
Virus Infection
11%
Fibrosis
11%
Biological Marker
10%
4,4' Isopropylidenediphenol
10%
Disease Course
10%
Heart Disease
10%
Mortality Rate
10%
Chemotherapy
10%
Coxsackievirus B3
10%
Prevalence
9%
Trastuzumab
9%
Autoimmune Disease
8%
Breast Cancer
8%
Randomized Clinical Trial
7%
Adverse Event
7%
Myoglobin
7%
Endothelin 1
7%
Thromboembolism
7%
Estrogen Receptor
7%
Disease Severity
7%
Circulating microRNA
7%
Environmental Influence
7%
Morquio Syndrome
7%
Cohort Study
7%
Infection
6%
microRNA
6%
Myocardial Disease
5%
Heart Infarction
5%